Le Lézard
Classified in: Business
Subjects: CCA, FVT

Chemours Announces Dates for Third Quarter 2017 Earnings Release and Webcast Conference Call


WILMINGTON, Del., Oct. 5, 2017 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, announced it will release third quarter financial results after market close on Thursday, November 2, 2017. The company will conduct its third quarter 2017 webcast conference call on Friday, November 3, 2017 at 8:30 a.m. Eastern Standard Time. The call is open to the public and can be accessed via live webcast and teleconference.

Conference Call:   Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides.

Replay:                   A webcast replay will be available at investors.chemours.com 

About The Chemours Company
The Chemours Company (NYSE: CC) helps create a colorful, capable and cleaner world through the power of chemistry.  Chemours is a global leader in titanium technologies, fluoroproducts and chemical solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations.  Chemours ingredients are found in plastics and coatings, refrigeration and air conditioning, mining and oil refining operations and general industrial manufacturing.  Our flagship products include prominent brands such as Teflontm, Ti-Puretm, Krytoxtm, Vitontm, Opteontm, Freontm and Nafiontm.  Chemours has approximately 7,000 employees and 26 manufacturing sites serving approximately 4,000 customers in North America, Latin America, Asia-Pacific and Europe.  Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC.  For more information please visit chemours.com.

CONTACT

MEDIA
Alvenia Scarborough
Director of Brand Marketing and Corporate Communications
+1.302.773.4507
[email protected] 

INVESTORS
Alisha Bellezza
Treasurer and Director of Investor Relations
+1.302.773.2263
[email protected]

SOURCE The Chemours Company


These press releases may also interest you

at 18:03
Revenue Revenue for the year was $238.5, down $1.4 from sales of $239.9 in 2022. The Company's  sales were flat when compared to 2022 and 2021 included a fifteen month period due to the accounting change from September 30 to December 31. Twelve-month...

at 18:02
Buhler Industries Inc. ("Buhler Industries or the Company"), the manufacturer of Versatile and Farm King brands of farm equipment, has made operational restructuring changes in the first quarter of 2024 that is expected to result in significant full...

at 18:01
Buhler Versatile Inc. ("Versatile"), a wholly owned subsidiary of Buhler Industries Inc. (Buhler Industries or the Company), has received $14.4 million Canadian ($10.7 million USD) in additional long term financing from its majority owner Ba?ak...

at 18:00
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen's Lab at Emory University School of Medicine....

at 17:52
In view of the passing of Thomas G. Kamp, a Director on the Board of Directors of The Taiwan Fund, Inc. (TWN) (the "Fund"), on March 20, 2024, the Board has approved amending the size of the Board to four Directors.  The Board will consider later in...

at 17:46
iA Financial Group today announces that the Annual Shareholder Meeting of iA Financial Corporation Inc. ("iA Financial Corporation") and the Annual Meeting of the Sole Common Shareholder and of the Participating Policyholders of Industrial Alliance...



News published on and distributed by: